← all works
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Advanced Drug Delivery Reviews
- Topic
- Nanoparticle-Based Drug Delivery
- Field
- Materials Science
- Canadian institutions
- —
- Funders
- National Institute of Biomedical Imaging and BioengineeringNational Cancer InstituteNational Heart, Lung, and Blood InstituteCanadian Institutes of Health Research
- Keywords
- CommercializationNanomedicineMedicineNanotechnologyTolerabilityCancerDrug developmentPersonalized medicineDrugPharmacologyNanoparticleBioinformaticsInternal medicineBusinessAdverse effectMaterials scienceBiology
- Has abstract in OpenAlex
- no